Literature DB >> 28940150

[Suicide risk in somatoform disorders].

Giancarlo Giupponi1, Ignazio Maniscalco2, Sandra Mathà1, Carlotta Ficco1, Georg Pernther1, Livia Sanna1, Maurizio Pompili3, Hans-Peter Kapfhammer4, Andreas Conca1.   

Abstract

BACKGROUND: The somatoform disorders include a group of complex disorders consist of somatic symptoms for which there are no identifiable organic cause or pathogenetic mechanisms. Given the importance of these disorders and the need to clarify the diagnosis of somatoform disorder affecting the suicide risk, we took into consideration the scientific literature to investigate the correlation between the two conditions.
METHODS: We performed a bibliographic search through Medline, Embase, PsycINFO, Scopus, SciELO, ORCID, Google Scholar, DOAJ using the following terms: somatoform, somatization disorder, pain disorder AND psychological factor, suicide, parasuicide, suicidality.
RESULTS: In all studies reported in our review, the suicidal behavior risk is high. But in the majority, the data are relatively unreliable because it takes into account the category nosographic "Neurotic, stress-related and somatoform disorders", too wide to be able to identify the clinical characteristics of patients at risk of only somatoform disorder.
CONCLUSIONS: Several studies conclude that psychiatric comorbidity increases the suicide risk: patients with two or more psychiatric disorders are more likely to commit a suicide attempt; in particular if there is a axis I diagnosis, the risk reduplicate. The somatization disorder seems to have a significant psychiatric comorbidity in particular with anxious and affective disorders spectrum.

Entities:  

Keywords:  Somatization; Somatoform; Suicidality; Suicide

Mesh:

Year:  2017        PMID: 28940150     DOI: 10.1007/s40211-017-0248-8

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  89 in total

Review 1.  The psychological autopsy approach to studying suicide: a review of methodological issues.

Authors:  K Hawton; L Appleby; S Platt; T Foster; J Cooper; A Malmberg; S Simkin
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

2.  Efficacy and safety of fluvoxamine in body dysmorphic disorder.

Authors:  K A Phillips; M M Dwight; S L McElroy
Journal:  J Clin Psychiatry       Date:  1998-04       Impact factor: 4.384

3.  Construct validity of the Anxiety Sensitivity Index-3 in clinical samples.

Authors:  Christoph J Kemper; Johannes Lutz; Tobias Bähr; Heinz Rüddel; Michael Hock
Journal:  Assessment       Date:  2011-12-06

4.  Childhood trauma, dissociation, and psychiatric comorbidity in patients with conversion disorder.

Authors:  Vedat Sar; Gamze Akyüz; Turgut Kundakçi; Emre Kiziltan; Orhan Dogan
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

5.  A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ralph S Albertini; Steven A Rasmussen
Journal:  Arch Gen Psychiatry       Date:  2002-04

6.  Emotional modulation of muscle pain is associated with polymorphisms in the serotonin transporter gene.

Authors:  Emilia Horjales-Araujo; Ditte Demontis; Ellen Kielland Lund; Lene Vase; Nanna Brix Finnerup; Anders D Børglum; Troels Staehelin Jensen; Peter Svensson
Journal:  Pain       Date:  2013-05-14       Impact factor: 6.961

7.  Migraine, suicidal ideation, and suicide attempts.

Authors:  N Breslau
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

8.  Depression and somatization: a review. Part I.

Authors:  W Katon; A Kleinman; G Rosen
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

9.  Suicidality in primary care patients with somatoform disorders.

Authors:  Jan F Wiborg; Dorothee Gieseler; Alexandra B Fabisch; Katharina Voigt; Anne Lautenbach; Bernd Löwe
Journal:  Psychosom Med       Date:  2013-10-22       Impact factor: 4.312

10.  Psychiatric disorders and clinical correlates of suicidal patients admitted to a psychiatric hospital in Tokyo.

Authors:  Naoki Hayashi; Miyabi Igarashi; Atsushi Imai; Yuka Osawa; Kaori Utsumi; Yoichi Ishikawa; Taro Tokunaga; Kayo Ishimoto; Hirohiko Harima; Yoshitaka Tatebayashi; Naoki Kumagai; Makoto Nozu; Hidetoki Ishii; Yuji Okazaki
Journal:  BMC Psychiatry       Date:  2010-12-13       Impact factor: 3.630

View more
  1 in total

1.  Using the Body When There Are No Words for Feelings: Alexithymia and Somatization in Self-Harming Adolescents.

Authors:  Alessia Raffagnato; Caterina Angelico; Perla Valentini; Marina Miscioscia; Michela Gatta
Journal:  Front Psychiatry       Date:  2020-04-08       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.